Xu X, Su J, Zhu R, Li K, Zhao X, Fan J
Mol Cancer. 2025; 24(1):63.
PMID: 40033282
PMC: 11874780.
DOI: 10.1186/s12943-025-02240-x.
Lai W, Geliang H, Bin X, Wang W
Mol Med. 2025; 31(1):83.
PMID: 40033190
PMC: 11877758.
DOI: 10.1186/s10020-025-01131-7.
Cong R, Lu C, Li X, Xu Z, Wang Y, Sun S
Pharm Biol. 2025; 63(1):89-109.
PMID: 39893515
PMC: 11789228.
DOI: 10.1080/13880209.2025.2458149.
Huang R, Zhu Y, Chen H, Yu L, Liu Z, Liu Y
Biomater Transl. 2025; 5(4):355-371.
PMID: 39872925
PMC: 11764192.
DOI: 10.12336/biomatertransl.2024.04.003.
Feng Q, Shan X, Yau V, Cai Z, Xie S
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861125
PMC: 11769033.
DOI: 10.3390/ph18010062.
Application of tumor organoids simulating the tumor microenvironment in basic and clinical research of tumor immunotherapy.
Li Y, Liao W, Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(8):1316-1326.
PMID: 39788520
PMC: 11628225.
DOI: 10.11817/j.issn.1672-7347.2024.240187.
Gut microbiota in health and disease: advances and future prospects.
Zhang Y, Wang H, Sang Y, Liu M, Wang Q, Yang H
MedComm (2020). 2024; 5(12):e70012.
PMID: 39568773
PMC: 11577303.
DOI: 10.1002/mco2.70012.
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics.
Mavingire N, Moore J, Johnson J, Dwead A, Cropp C, Mechref Y
Cancers (Basel). 2024; 16(19).
PMID: 39409883
PMC: 11476348.
DOI: 10.3390/cancers16193262.
Understanding neurotropic enteric viruses: routes of infection and mechanisms of attenuation.
Lulla V, Sridhar A
Cell Mol Life Sci. 2024; 81(1):413.
PMID: 39365457
PMC: 11452578.
DOI: 10.1007/s00018-024-05450-6.
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.
Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L
MedComm (2020). 2024; 5(10):e735.
PMID: 39309690
PMC: 11416091.
DOI: 10.1002/mco2.735.
Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.
Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P
J Exp Clin Cancer Res. 2024; 43(1):259.
PMID: 39261955
PMC: 11389238.
DOI: 10.1186/s13046-024-03173-x.
Advancements in Research and Treatment Applications of Patient-Derived Tumor Organoids in Colorectal Cancer.
van der Graaff D, Seghers S, Vanclooster P, Deben C, Vandamme T, Prenen H
Cancers (Basel). 2024; 16(15).
PMID: 39123399
PMC: 11311786.
DOI: 10.3390/cancers16152671.
Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development.
Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T
Theranostics. 2024; 14(8):3300-3316.
PMID: 38855182
PMC: 11155402.
DOI: 10.7150/thno.96027.
Guidelines for Packaging, Transport, and Storage of Source Cells for Organoids.
Lee S, Kwon D, Lee H, Jeon S, Park C, Kim T
Int J Stem Cells. 2024; 17(2):113-119.
PMID: 38735854
PMC: 11170112.
DOI: 10.15283/ijsc24042.
Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research.
Yan S, He Y, Zhu Y, Ye W, Chen Y, Zhu C
Front Cell Dev Biol. 2024; 12:1384450.
PMID: 38638528
PMC: 11024315.
DOI: 10.3389/fcell.2024.1384450.
Orthotopic and metastatic tumour models in preclinical cancer research.
Stribbling S, Beach C, Ryan A
Pharmacol Ther. 2024; 257:108631.
PMID: 38467308
PMC: 11781865.
DOI: 10.1016/j.pharmthera.2024.108631.
Constructing Tumor Organoid-like Tissue for Reliable Drug Screening Using Liver-Decellularized Extracellular Matrix Scaffolds.
Chen Z, Long L, Wang J, Li W, Wang A, Kankala R
ACS Omega. 2024; 9(5):5888-5898.
PMID: 38343980
PMC: 10851408.
DOI: 10.1021/acsomega.3c09265.
Towards Automation in 3D Cell Culture: Selective and Gentle High-Throughput Handling of Spheroids and Organoids via Novel Pick-Flow-Drop Principle.
Zieger V, Frejek D, Zimmermann S, Miotto G, Koltay P, Zengerle R
Adv Healthc Mater. 2024; 13(9):e2303350.
PMID: 38265410
PMC: 11468932.
DOI: 10.1002/adhm.202303350.
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies.
Ottaiano A, Ianniello M, Santorsola M, Ruggiero R, Sirica R, Sabbatino F
Biology (Basel). 2023; 12(9).
PMID: 37759584
PMC: 10525472.
DOI: 10.3390/biology12091183.
Tumor Organoid and Spheroid Models for Cervical Cancer.
Kutle I, Polten R, Hachenberg J, Klapdor R, Morgan M, Schambach A
Cancers (Basel). 2023; 15(9).
PMID: 37173984
PMC: 10177622.
DOI: 10.3390/cancers15092518.